No price history available.
Key financial summary
Financials in ZAC| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ZACm | 26,278 | 30,407 | 32,664 | 36,283 | 39,172 | 42,826 | N/A | N/A |
| Operating profit | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ZACm | 669 | 853 | 1,000 | 984 | 1,180 | 979 | N/A | N/A |
| EPS reported | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in ZAC| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Dis-Chem Pharmacies Limited (DCP.JO) is a leading South African enterprise engaged in both the retail and wholesale supply of healthcare products and pharmaceuticals. The company operates through two distinct segments: Retail and Wholesale. Its extensive retail network encompasses numerous stores that provide a wide array of offerings, including dispensary services, personal care and beauty products, health and nutrition items, and baby essentials. These outlets further enhance their customer experience by offering ancillary services like healthcare clinics and hair and beauty salons. Dis-Chem also maintains an online platform that facilitates convenient click & collect services for its customers. On the wholesale front, the company handles the distribution of pharmaceutical, health, and general front-shop products, delivers specialized pharma-logistic solutions, and manages customer loyalty initiatives. Established in 1978 and headquartered in Midrand, South Africa, Dis-Chem boasts a substantial presence with 289 stores spread across all nine South African provinces, supplemented by four outlets in Namibia and two in Botswana.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Dis-Chem Pharmacies Limited (DCP.JO)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Dis-Chem Pharmacies Limited (DCP.JO) is a leading South African enterprise engaged in both the retail and wholesale supply of healthcare products and pharmaceuticals. The company operates through two distinct segments: Retail and Wholesale. Its extensive retail network encompasses numerous stores that provide a wide array of offerings, including dispensary services, personal care and beauty products, health and nutrition items, and baby essentials. These outlets further enhance their customer experience by offering ancillary services like healthcare clinics and hair and beauty salons. Dis-Chem also maintains an online platform that facilitates convenient click & collect services for its customers. On the wholesale front, the company handles the distribution of pharmaceutical, health, and general front-shop products, delivers specialized pharma-logistic solutions, and manages customer loyalty initiatives. Established in 1978 and headquartered in Midrand, South Africa, Dis-Chem boasts a substantial presence with 289 stores spread across all nine South African provinces, supplemented by four outlets in Namibia and two in Botswana.